BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 2559316)

  • 1. New Escherichia coli gyrA and gyrB mutations which have a graded effect on DNA supercoiling.
    Aleixandre V; Urios A; Herrera G; Blanco M
    Mol Gen Genet; 1989 Oct; 219(1-2):306-12. PubMed ID: 2559316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discoordinate gene expression of gyrA and gyrB in response to DNA gyrase inhibition in Escherichia coli.
    Neumann S; Quiñones A
    J Basic Microbiol; 1997; 37(1):53-69. PubMed ID: 9090126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of DNA gyrase inhibitors in Escherichia coli topoisomerase I mutants.
    Pruss GJ; Franco RJ; Chevalier SG; Manes SH; Drlica K
    J Bacteriol; 1986 Oct; 168(1):276-82. PubMed ID: 3019999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ciprofloxacin on plasmid DNA supercoiling of Escherichia coli topoisomerase I and gyrase mutants.
    Aleixandre V; Herrera G; Urios A; Blanco M
    Antimicrob Agents Chemother; 1991 Jan; 35(1):20-3. PubMed ID: 1849710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of gyrA and parC mutations on quinolone resistance, doubling time, and supercoiling degree of Escherichia coli.
    Bagel S; Hüllen V; Wiedemann B; Heisig P
    Antimicrob Agents Chemother; 1999 Apr; 43(4):868-75. PubMed ID: 10103193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinolone action in Escherichia coli cells carrying gyrA and gyrB mutations.
    Herrera G; Aleixandra V; Urios A; Blanco M
    FEMS Microbiol Lett; 1993 Jan; 106(2):187-91. PubMed ID: 8384139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. gyrB-225, a mutation of DNA gyrase that compensates for topoisomerase I deficiency: investigation of its low activity and quinolone hypersensitivity.
    Heddle JG; Lu T; Zhao X; Drlica K; Maxwell A
    J Mol Biol; 2001 Jun; 309(5):1219-31. PubMed ID: 11399091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ciprofloxacin and the fluoroquinolones. New concepts on the mechanism of action and resistance.
    Fisher LM; Lawrence JM; Josty IC; Hopewell R; Margerrison EE; Cullen ME
    Am J Med; 1989 Nov; 87(5A):2S-8S. PubMed ID: 2574005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of Staphylococcus aureus.
    Ito H; Yoshida H; Bogaki-Shonai M; Niga T; Hattori H; Nakamura S
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2014-23. PubMed ID: 7811012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinolone-resistant mutations of DNA gyrase increase sensitivity to acriflavine.
    Funatsuki K; Tanaka R; Inagaki S; Konno H; Katoh K; Nakamura H
    Biol Pharm Bull; 1998 Jul; 21(7):667-72. PubMed ID: 9703246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous quinolone resistance in Serratia marcescens due to a mutation in gyrA.
    Masecar BL; Robillard NJ
    Antimicrob Agents Chemother; 1991 May; 35(5):898-902. PubMed ID: 1649573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gyrase inhibitors can increase gyrA expression and DNA supercoiling.
    Franco RJ; Drlica K
    J Bacteriol; 1989 Dec; 171(12):6573-9. PubMed ID: 2556367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in topoisomerase IV and DNA gyrase of Staphylococcus aureus: novel pleiotropic effects on quinolone and coumarin activity.
    Fournier B; Hooper DC
    Antimicrob Agents Chemother; 1998 Jan; 42(1):121-8. PubMed ID: 9449271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular cloning of the gyrA and gyrB genes of Bacteroides fragilis encoding DNA gyrase.
    Onodera Y; Sato K
    Antimicrob Agents Chemother; 1999 Oct; 43(10):2423-9. PubMed ID: 10508019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel, double mutation in DNA gyrase A of Escherichia coli conferring resistance to quinolone antibiotics.
    Truong QC; Nguyen Van JC; Shlaes D; Gutmann L; Moreau NJ
    Antimicrob Agents Chemother; 1997 Jan; 41(1):85-90. PubMed ID: 8980760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a nalidixic-acid-resistant mutant of Escherichia coli as a strict aerobe.
    Yoshizawa Y; Yamamoto N
    Microbiol Immunol; 1989; 33(6):449-57. PubMed ID: 2549346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Escherichia coli DNA topoisomerase I mutants: increased supercoiling is corrected by mutations near gyrase genes.
    Pruss GJ; Manes SH; Drlica K
    Cell; 1982 Nov; 31(1):35-42. PubMed ID: 6297751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression in Escherichia coli of Y5 mutant and N-terminal domain-deleted DNA gyrase B proteins affects strongly plasmid maintenance.
    Brino L; Mousli M; Oudet P; Weiss E
    Plasmid; 1998; 39(1):21-34. PubMed ID: 9473443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of biodegradative threonine dehydratase of Escherichia coli by DNA gyrase inhibitors.
    Sumantran VN; Tranguch AJ; Datta P
    FEMS Microbiol Lett; 1989 Nov; 53(1-2):37-40. PubMed ID: 2558950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA supercoiling in gyrase mutants.
    Steck TR; Pruss GJ; Manes SH; Burg L; Drlica K
    J Bacteriol; 1984 May; 158(2):397-403. PubMed ID: 6327603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.